Health Care

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

Eli Lilly reported a 7.2 percent rise in quarterly revenue, lifted by higher demand for its diabetes drug Trulicity and other new treatments.

Health insurer Aetna, whose $34 billion deal for Humana was blocked last week, reported a higher-than-expected quarterly profit on Tuesday, helped by higher premiums for its plans.

U.S. President Donald Trump, who has criticized the high prices of prescription drugs, will meet with representatives of the pharmaceutical industry on Tuesday at the White House.

More than 100,000 notebook batteries are being recalled as part of an expanded recall because they can overheat, posing a fire hazard.

Colgate-Palmolive reported an adjusted 4Q profit of $0.75 per share, topping, missing the estimate for $0.75. Revenue for the company came in at $3.72 billion, missing the estimate for $3.86 billion

Federal prosecutors say two owners of psychological service companies have been convicted of an $8.9 million fraud scheme that billed Medicare for unnecessary or nonexistent tests on nursing home patients in four Gulf Coast states.

Johnson & Johnson is buying Swiss biopharmaceutical company Actelion Ltd. for about $30 billion, handing the U.S.-based health care products giant a chance to boost its presence in innovative biotech treatments.

Is getting rid of the ACA as simple as Trump signing his name? Not quite. There are a few problems to consider, one of which it seems is getting overlooked.

Johnson & Johnson will acquire Swiss biotech company Actelion in a $30 billion all-cash deal.

Bristol-Myers Squibb Co. (BMY) on Thursday reported fourth-quarter net income of $894 million, after reporting a loss in the same period a year earlier.

Former Buffalo Bills quarterback Jim Kelly discussed his new partnership with Merck to create ‘Your Cancer Game Plan’ in an effort to help people with cancer, and their loved ones, stay informed during their fight against the disease.

The doctor for Bill and Hillary Clinton weighs in on what he says is the real problem facing Americans today—obesity.

Swiss pharmaceutical company Novartis says it is considering options for its Alcon eye-care products division, and announced plans to increase its dividend by 2 percent and buy back $5 billion worth of shares this year.

Toyota says it's recalling about 79,000 Tundra pickup trucks in the U.S., Canada and Central America because steps in the rear bumpers could break.

Johnson & Johnson (JNJ) on Tuesday reported fourth-quarter net income of $3.81 billion.

Former White House Office of Management and Budget Advisor, and one of the architects of Obamacare, Dr. Ezekiel Emanuel reacted to Republican efforts to repeal and replace the Affordable Care Act and President Trump’s calls to rein in drug prices.

Johnson & Johnson reported a smaller-than-expected rise in fourth-quarter sales, hurt by slowing demand for its medical devices and a stronger dollar.

A federal judge has rejected health insurer Aetna's plan to buy rival Humana Inc. for about $34 billion and become a major player in the market for Medicare Advantage coverage.